PMC5499864_01
Effect of PDAI on treatment decisions for (A) nonadherent patients (results represent average from 3 vignettes), (B) adherent but poorly controlled patients (results represent average from 2 vignettes), and (C) adherent and well-controlled patients. The P-values were calculated based on a multinomial logistic regression performing pairwise comparison of each treatment decision pair across the 2 groups of respondents, adjusting for multiple comparisons using false discovery rate-adjustment.. Notes: **P<0.01. The bars without an asterisks are not statistically significant.. Abbreviations: PDAI, patient drug adherence information; LAI, long-acting injectable.
ppa-11-1071Fig3.jpg
PMC5499864_02_ppa-11-1071Fig3.jpg
f3-ppa-11-1071
Figure 3B summarizes the prescribers' treatment approaches in response to these 2 vignettes. A chi2 test indicated that the differences across all choices by group were not statistically significant (P=0.099; Figure 3C).
PMC5499864_02
Effect of PDAI on treatment decisions for (A) nonadherent patients (results represent average from 3 vignettes), (B) adherent but poorly controlled patients (results represent average from 2 vignettes), and (C) adherent and well-controlled patients. The P-values were calculated based on a multinomial logistic regression performing pairwise comparison of each treatment decision pair across the 2 groups of respondents, adjusting for multiple comparisons using false discovery rate-adjustment.. Notes: **P<0.01. The bars without an asterisks are not statistically significant.. Abbreviations: PDAI, patient drug adherence information; LAI, long-acting injectable.
ppa-11-1071Fig3.jpg
PMC5499864_02_ppa-11-1071Fig3.jpg
f3-ppa-11-1071
Figure 3B summarizes the prescribers' treatment approaches in response to these 2 vignettes. A chi2 test indicated that the differences across all choices by group were not statistically significant (P=0.099; Figure 3C).